I used to have a favorite pen. Now I have a favorite pulse oximeter. Things that once would have seemed intimidating, complicated, or downright bizarre have become part of everyday life. Living with pulmonary hypertension (PH) means noticing details most people can afford to ignore. I pay attention…
Discussion
Artificial intelligence (AI) tools using machine learning may help doctors predict how a pulmonary arterial hypertension (PAH) patient’s ability to walk might change over the next year, a study from Germany found. The researchers said more study is needed before the machine learning model, which uses clinical data available…
Discussion
Note: This story was updated Sept. 30, 2026, to clarify that the Chiesi Group is no longer collaborating with Gossamer Bio in the development, regulatory activities, or commercialization of seralutinib. Gossamer Bio has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval of seralutinib, an…
Discussion
The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Winrevair (sotatercept-csrk), an approved injection therapy for adults with pulmonary arterial hypertension (PAH) marketed by Merck. The most notable change in this update is the addition of a contraindication (a…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
